Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +2.5% | ▲ +8.3% | ▲ +13.1% | ▲ +21.9% | — | — | — | ▲ +22.7% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Official documents are being connected from SEC EDGAR. Read the issuer’s prospectus before investing.
The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-24 | 2025-12-26 | $0.02 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind PBPH.